ProJenX

New Suffolk, United States

ProJenX is a biopharmaceutical company that develops novel small molecule therapeutics that target motor neuron degenerative pathways.

Jun 2024

Grant

Top Investors

Medical Excellence CapitalThe ALS Association

19,000+ verified contacts

Emails, phones & LinkedIn profiles

Who are ProJenX's investors?

ProJenX's investors include Medical Excellence Capital, The ALS Association.

Where is ProJenX headquartered?

ProJenX is headquartered in New Suffolk, United States.

What does ProJenX do?

ProJenX is a biopharmaceutical company that develops novel small molecule therapeutics that target motor neuron degenerative pathways.

What stage is ProJenX at?

ProJenX is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 20, 2024.

MLA

"ProJenX — Funding & Investors." VCBacked, June 20, 2024, https://www.vcbacked.co/company/projenx. Accessed July 1, 2026.

APA

VCBacked. (2024). ProJenX — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/projenx

Wikipedia (cite web)

{{cite web |title=ProJenX — Funding & Investors |url=https://www.vcbacked.co/company/projenx |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 20, 2024.